U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


WIRTH PETER (0001021041)
SIC: 2836 - Biological Products, (No Diagnostic Substances)
| State of Inc.: MA | Fiscal Year End: 1231
Mailing Address
37 HANCOCK STREET
BOSTON MA 02114
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
Syros Pharmaceuticals, Inc. 0001556263 2024-06-05 director
Zai Lab Ltd
Current Name:Forma Therapeutics Holdings, Inc.		 0001704292 2021-01-01 director
Forma Therapeutics Holdings, Inc.,
Current Name:Forma Therapeutics Holdings, Inc.		 0001538927 2020-06-18 director
TRIMERIS INC
Current Name:SYNAGEVA BIOPHARMA CORP		 0000911326 2015-06-22 director
EPIX Pharmaceuticals, Inc. 0001027702 2004-05-26 director
GENZYME CORP 0000732485 2003-06-30 officer: Executive Vice President


Items 1 - 80

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name
A 2024-06-18   Zai Lab Ltd 4 A-Award --D 21253.0000 382919.0000 1 0001704292 American Depositary Shares
A 2024-06-05   Syros Pharmaceuticals, Inc. 4 A-Award --D 6000.0000 6000.0000 2 0001556263 Stock Option (right to buy)
A 2024-06-05   Syros Pharmaceuticals, Inc. 4 A-Award --D 4000.0000 16000.0000 1 0001556263 Common Stock
A 2023-06-29   Zai Lab Ltd 4 A-Award --D 18903.0000 361666.0000 1 0001704292 American Depositary Shares
A 2023-06-01   Syros Pharmaceuticals, Inc. 4 A-Award --D 6000.0000 6000.0000 2 0001556263 Stock Option (right to buy)
A 2023-06-01   Syros Pharmaceuticals, Inc. 4 A-Award --D 4000.0000 12000.0000 1 0001556263 Common Stock
D 2022-12-08   Zai Lab Ltd 4 S-Sale --I 4000.0000 0.0000 2 0001704292 American Depositary Shares
D 2022-12-08   Zai Lab Ltd 4 S-Sale --D 3852.0000 342763.0000 1 0001704292 American Depositary Shares
D 2022-10-14   Forma Therapeutics Holdings, Inc. 4 D-Return --D 6750.0000 0.0000 7 0001538927 Stock Option (Right to Buy)
D 2022-10-14   Forma Therapeutics Holdings, Inc. 4 D-Return --D 8375.0000 0.0000 6 0001538927 Stock Option (Right to Buy)
D 2022-10-14   Forma Therapeutics Holdings, Inc. 4 D-Return --D 17533.0000 0.0000 5 0001538927 Stock Option (Right to Buy)
D 2022-10-14   Forma Therapeutics Holdings, Inc. 4 D-Return --D 28053.0000 0.0000 4 0001538927 Stock Option (Right to Buy)
D 2022-10-14   Forma Therapeutics Holdings, Inc. 4 D-Return --D 14026.0000 0.0000 3 0001538927 Stock Option (Right to Buy)
D 2022-10-14   Forma Therapeutics Holdings, Inc. 4 U-Tender --D 7250.0000 0.0000 2 0001538927 Common Stock
D 2022-10-14   Forma Therapeutics Holdings, Inc. 4 U-Tender --D 127665.0000 0.0000 1 0001538927 Common Stock
A 2022-09-16   Syros Pharmaceuticals, Inc. 4 A-Award --D 12000.0000 12000.0000 2 0001556263 Stock Option (right to buy)
A 2022-09-16   Syros Pharmaceuticals, Inc. 4 A-Award --D 8000.0000 8000.0000 1 0001556263 Common Stock
A 2022-06-08   Forma Therapeutics Holdings, Inc. 4 A-Award --D 6750.0000 6750.0000 2 0001538927 Stock Option (Right to Buy)
A 2022-06-08   Forma Therapeutics Holdings, Inc. 4 A-Award --D 4500.0000 134915.0000 1 0001538927 Common Stock
A 2022-06-01   Syros Pharmaceuticals, Inc. 4 A-Award --D 17500.0000 17500.0000 1 0001556263 Stock Option (right to buy)
A 2022-01-03   Zai Lab Ltd 4 A-Award --D 7763.0000 350615.0000 1 0001704292 Ordinary Shares
A 2021-12-08   Zai Lab Ltd 4/A P-Purchase --I 4000.0000 4000.0000 1 0001704292 American Depositary Shares
A 2021-12-08   Zai Lab Ltd 4 P-Purchase --D 4000.0000 342852.0000 1 0001704292 Ordinary Shares
A 2021-06-17   Forma Therapeutics Holdings, Inc. 4 A-Award --D 8375.0000 8375.0000 2 0001538927 Stock Option (Right to Buy)
A 2021-06-17   Forma Therapeutics Holdings, Inc. 4 A-Award --D 2750.0000 130415.0000 1 0001538927 Common Stock
A 2021-06-08   Syros Pharmaceuticals, Inc. 4 A-Award --D 17500.0000 17500.0000 1 0001556263 Stock Option (right to buy)
A 2021-01-15   Zai Lab Ltd 4 A-Award --D 3852.0000 338852.0000 1 0001704292 Ordinary Shares
D 2020-06-23   Forma Therapeutics Holdings, Inc., 4 S-Sale --D 14026.0000 0.0000 6 0001538927 Enterprise 5 Junior Stock
D 2020-06-23   Forma Therapeutics Holdings, Inc., 4 S-Sale --D 10240.0000 0.0000 5 0001538927 Enterprise 4 Junior Stock
D 2020-06-23   Forma Therapeutics Holdings, Inc., 4 S-Sale --D 9847.0000 0.0000 4 0001538927 Enterprise 3 Junior Stock
D 2020-06-23   Forma Therapeutics Holdings, Inc., 4 S-Sale --D 18585.0000 0.0000 3 0001538927 Enterprise 2 Junior Stock
D 2020-06-23   Forma Therapeutics Holdings, Inc., 4 S-Sale --D 25756.0000 0.0000 2 0001538927 Enterprise 1 Junior Stock
A 2020-06-23   Forma Therapeutics Holdings, Inc., 4 P-Purchase --D 63299.0000 127665.0000 1 0001538927 Common Stock
A 2020-06-18   Forma Therapeutics Holdings, Inc., 4 A-Award --D 17533.0000 0.0000 1 0001538927 Stock Option (Right to Buy)
A 2020-06-11   Syros Pharmaceuticals, Inc. 4 A-Award --D 17500.0000 17500.0000 1 0001556263 Stock Option (right to buy)
A 2019-06-11   Syros Pharmaceuticals, Inc. 4 A-Award --D 11000.0000 11000.0000 1 0001556263 Stock Option (right to buy)
A 2018-06-14   Syros Pharmaceuticals, Inc. 4 A-Award --D 11000.0000 11000.0000 1 0001556263 Stock Option (right to buy)
A 2017-01-27   Syros Pharmaceuticals, Inc. 4 A-Award --D 22000.0000 22000.0000 1 0001556263 Stock Option (Right to Buy)
D 2015-06-22   SYNAGEVA BIOPHARMA CORP 4 D-Return --D 7500.0000 0.0000 3 0000911326 Stock Options (Right to Buy)
D 2015-06-22   SYNAGEVA BIOPHARMA CORP 4 D-Return --D 15000.0000 0.0000 2 0000911326 Stock Options (Right to Buy)
D 2015-06-22   SYNAGEVA BIOPHARMA CORP 4 D-Return --D 7500.0000 0.0000 1 0000911326 Stock Options (Right to Buy)
A 2014-06-04   SYNAGEVA BIOPHARMA CORP 4 A-Award --D 7500.0000 7500.0000 1 0000911326 Stock Option (Right to Buy)
A 2013-06-06   SYNAGEVA BIOPHARMA CORP 4 A-Award --D 7500.0000 7500.0000 1 0000911326 Stock Option (Right to Buy)
A 2012-06-27   SYNAGEVA BIOPHARMA CORP 4 A-Award --D 15000.0000 15000.0000 1 0000911326 Stock Option (Right to Buy)
D 2011-04-04   GENZYME CORP 4 D-Return --D 62000.0000 0.0000 19 0000732485 Stock Option (right to buy)
D 2011-04-04   GENZYME CORP 4 D-Return --D 15375.0000 0.0000 18 0000732485 Stock Option (right to buy)
D 2011-04-04   GENZYME CORP 4 D-Return --D 169925.0000 0.0000 17 0000732485 Stock Option (right to buy)
D 2011-04-04   GENZYME CORP 4 D-Return --D 2245.0000 0.0000 16 0000732485 Stock Option (right to buy)
D 2011-04-04   GENZYME CORP 4 D-Return --D 90000.0000 0.0000 15 0000732485 Stock Option (right to buy)
D 2011-04-04   GENZYME CORP 4 D-Return --D 81000.0000 0.0000 14 0000732485 Stock Option (right to buy)
D 2011-04-04   GENZYME CORP 4 D-Return --D 69000.0000 0.0000 13 0000732485 Stock Option (right to buy)
D 2011-04-04   GENZYME CORP 4 D-Return --D 69000.0000 0.0000 12 0000732485 Stock Option (right to buy)
D 2011-04-04   GENZYME CORP 4 D-Return --D 45000.0000 0.0000 11 0000732485 Stock Option (right to buy)
D 2011-04-04   GENZYME CORP 4 D-Return --D 45000.0000 0.0000 10 0000732485 Stock Option (right to buy)
D 2011-04-04   GENZYME CORP 4 D-Return --D 42750.0000 0.0000 9 0000732485 Stock Option (right to buy)
D 2011-04-04   GENZYME CORP 4 D-Return --D 42750.0000 0.0000 8 0000732485 Stock Option (right to buy)
D 2011-04-04   GENZYME CORP 4 M-Exempt --D 15000.0000 0.0000 7 0000732485 Restricted Stock Units
D 2011-04-04   GENZYME CORP 4 M-Exempt --D 14250.0000 0.0000 6 0000732485 Restricted Stock Units
D 2011-04-04   GENZYME CORP 4 U-Tender --I 148.0000 0.0000 5 0000732485 Genzyme common stock (GENZ)
D 2011-04-04   GENZYME CORP 4 D-Return --D 29250.0000 0.0000 4 0000732485 Genzyme common stock (GENZ)
D 2011-04-04   GENZYME CORP 4 U-Tender --D 15660.0000 29250.0000 3 0000732485 Genzyme common stock (GENZ)
A 2011-04-04   GENZYME CORP 4 M-Exempt --D 14250.0000 44910.0000 2 0000732485 Genzyme common stock (GENZ)
A 2011-04-04   GENZYME CORP 4 M-Exempt --D 15000.0000 30660.0000 1 0000732485 Genzyme common stock (GENZ)
A 2010-06-16   GENZYME CORP 4 A-Award --D 42750.0000 42750.0000 1 0000732485 Stock Option (right to buy)
D 2010-05-25   GENZYME CORP 4 S-Sale --D 6665.0000 15191.0000 2 0000732485 Genzyme common stock (GENZ)
D 2010-05-24   GENZYME CORP 4 M-Exempt --D 15000.0000 0.0000 4 0000732485 Restricted Stock Units
A 2010-05-24   GENZYME CORP 4 M-Exempt --D 15000.0000 21856.0000 1 0000732485 Genzyme common stock (GENZ)
D 2010-05-17 2010-05-17 GENZYME CORP 4 M-Exempt --D 48216.0000 0.0000 4 0000732485 Stock Option (right to buy)
D 2010-05-17 2010-05-17 GENZYME CORP 4 S-Sale --D 48216.0000 6856.0000 2 0000732485 Genzyme common stock (GENZ)
A 2010-05-17 2010-05-17 GENZYME CORP 4 M-Exempt --D 48216.0000 55072.0000 1 0000732485 Genzyme common stock (GENZ)
A 2009-05-21   GENZYME CORP 4 A-Award --D 14250.0000 14250.0000 1 0000732485 Restricted Stock Units
A 2009-05-21   GENZYME CORP 4 A-Award --D 42750.0000 42750.0000 2 0000732485 Stock Option (right to buy)
D 2009-01-16 2009-01-16 GENZYME CORP 4 M-Exempt --D 232180.0000 0.0000 4 0000732485 Genzyme NQ stock option (right to buy)
A 2009-01-16 2009-01-16 GENZYME CORP 4 M-Exempt --D 232180.0000 238248.0000 1 0000732485 Genzyme common stock (GENZ)
D 2009-01-16 2009-01-16 GENZYME CORP 4 S-Sale --D 232180.0000 6068.0000 2 0000732485 Genzyme common stock (GENZ)
A 2008-05-22   GENZYME CORP 4 A-Award --D 15000.0000 15000.0000 2 0000732485 Genzyme Restricted Stock Units
A 2008-05-22   GENZYME CORP 4 A-Award --D 45000.0000 45000.0000 1 0000732485 Genzyme NQ Stock Option (right to buy)
A 2007-05-24   GENZYME CORP 4 A-Award --D 36960.0000 36960.0000 2 0000732485 Genzyme NQ Stock Option (right to buy)
A 2007-05-24   GENZYME CORP 4 A-Award --D 15000.0000 15000.0000 3 0000732485 Genzyme Restricted Stock Units
A 2007-05-24   GENZYME CORP 4 A-Award --D 8040.0000 8040.0000 1 0000732485 Genzyme ISO stock option (right to buy)

http://www.sec.gov/cgi-bin/own-disp

Home | Search Home | Previous Page
Modified: 04/22/2016